1
|
Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers.
|
Hepatology
|
2010
|
2.02
|
2
|
SeqHepB: a sequence analysis program and relational database system for chronic hepatitis B.
|
Antiviral Res
|
2006
|
1.16
|
3
|
Molecular and clinical characteristics of hepatitis B virus in Korea.
|
J Med Virol
|
2010
|
0.95
|
4
|
Patterns and causes of suboptimal response to tenofovir-based therapy in individuals coinfected with HIV and hepatitis B virus.
|
Clin Infect Dis
|
2013
|
0.93
|
5
|
Molecular epidemiology of hepatitis B in the Indigenous people of northern Australia.
|
J Gastroenterol Hepatol
|
2013
|
0.93
|
6
|
Quantification of HBV covalently closed circular DNA from liver tissue by real-time PCR.
|
Methods Mol Med
|
2004
|
0.90
|
7
|
Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals.
|
AIDS
|
2007
|
0.88
|
8
|
Possible origins and evolution of the hepatitis B virus (HBV).
|
Semin Cancer Biol
|
2013
|
0.88
|
9
|
Defective hepatitis B virus DNA is not associated with disease status but is reduced by polymerase mutations associated with drug resistance.
|
Hepatology
|
2008
|
0.86
|
10
|
In vitro replication phenotype of a novel (-1G) hepatitis B virus variant associated with HIV co-infection.
|
J Med Virol
|
2012
|
0.81
|
11
|
Quantitative HBsAg and HBeAg predict hepatitis B seroconversion after initiation of HAART in HIV-HBV coinfected individuals.
|
PLoS One
|
2013
|
0.79
|
12
|
HBV mutations in untreated HIV-HBV co-infection using genomic length sequencing.
|
Virology
|
2010
|
0.79
|
13
|
Understanding the resilience of mail-back survey methods: An analysis of 20years of change in response rates to national park surveys.
|
Soc Sci Res
|
2012
|
0.78
|
14
|
Factors associated with elevated ALT in an international HIV/HBV co-infected cohort on long-term HAART.
|
PLoS One
|
2011
|
0.77
|
15
|
Effects of long-term tenofovir-based combination antiretroviral therapy in HIV-hepatitis B virus coinfection on persistent hepatitis B virus viremia and the role of hepatitis B virus quasispecies diversity.
|
AIDS
|
2016
|
0.75
|